drugset
drugset / Trial / NCT03260010

Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection

NCT03260010 ↗

Phase 4 Unknown 224 enrolled Pro-Implant Foundation Charite University, Berlin, Germany · collab
NaSingle-groupOpen-labelTreatment

Summary

The PROOF Study is an open prospective interventional non-randomized study which aim is to determine the outcome / effect and safety of fosfomycin in patients with hip, knee or shoulder PJI.

Timeline

Start
2018-01-15
Primary completion
2020-04-15
Completion
2021-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Fosfomycin Small molecule 5 g —

Indications

periprosthetic joint infection